Novel Tricyclic Compounds

Patent No. EP2506716 (titled "Novel Tricyclic Compounds") was filed by Abbott on Dec 1, 2010. The application was issued on May 17, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKFeb 16, 2018TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2506716

ABBOTT
Application Number
EP10835061A
Filing Date
Dec 1, 2010
Status
Opposition Rejected
Nov 22, 2019
Publication Date
May 17, 2017